Drug-induced infiltrative lung disease

European Respiratory Journal, Supplement

Volumn 18, Issue 32, 2001, Pages

  Camus, Ph ^a   Foucher, P ^a   Bonniaud, Ph ^a   Ask, K ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Drug induced lung disease; Drugs; Lung toxicity; Patients; Registry; Web technology

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BCG VACCINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLEOMYCIN; BUSULFAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOT DERIVATIVE; FIBRINOLYTIC AGENT; GOLD; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON; METHOTREXATE; NILUTAMIDE; NITROFURANTOIN; NITROSOUREA DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PROPYLTHIOURACIL;

ANTIINFLAMMATORY ACTIVITY; DRUG INDUCED DISEASE; HUMAN; INTERNET; LUNG DISEASE; LUNG INFILTRATE; LUNG TOXICITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; DRUG HYPERSENSITIVITY; DRUG THERAPY; EUROPE; FORECASTING; IATROGENIC DISEASE; INTERSTITIAL LUNG DISEASE; PROGNOSIS;

DRUG HYPERSENSITIVITY; DRUG THERAPY; EUROPE; FORECASTING; HUMAN; LUNG DISEASES, INTERSTITIAL; PROGNOSIS; RISK FACTORS;

EID: 0035744661     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Drug-induced adverse pulmonary reactions
2. Drug-induced pulmonary disease. Part II: Noncytotoxic drugs
3. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs
4. Drug-induced pulmonary disease: An update
5. Drugs that may injure the respiratory system
6. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium
7. Drugs and the pleura
8. Amiodarone pneumonitis: Bronchoalveolar lavage findings in 15 patients and review of the literature
9. Exogenous lipid pneumonia: A retrospective multicentre study of 44 cases in France
10. The crazy-paving pattern in exogenous lipoid pneumonia: CT-pathologic correlation
11. Drug-induced pulmonary disease
12. Drug-induced lung disease
13. Drug-induced lung disease
14. Respiratory disease induced by drugs
15. Clinical organ toxicity of antiarrhythmic compounds: Ocular and pulmonary manifestations
16. Drug-induced respiratory disorders. Incidence, prevention and management
17. Methotrexate pneumonitis: Review of the literature and histopathological findings in nine patients
18. Pneumopathies interstitielles: Critères d'imputation à un médicament
19. Interferon-alpha therapy associated with the development of sarcoidosis
20. Probable cutaneous sarcoidosis associated with combined interferon-alpha and ribavirin therapy for chronic hepatitis C
21. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia
22. Sarcoidosis and IFN-alpha treatment
23. Interferon-related bronchiolitis obliterans organizing pneumonia
24. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies
25. Transient pulmonary infiltrates during treatment with anti-thymocyte globulin
26. All-transretinoic acid related pulmonary syndrome
27. Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA - A manifestation of the basic disease or the treatment
28. Pulmonary toxicity of chemotherapy and G/GM-CSF: A report of five cases
29. Fatal G-CSF-induced pulmonary toxicity
30. Case records of the Massachusetts General Hospital - Case 40-1998
31. Transfusion-related lung injury
32. Pulmonary cytolytic thrombi: A newly recognized complication of stem cell transplantation
33. Two cases of pneumonia caused by Sho-saiko-to
34. Harmless herbs? A review of the recent literature
35. Urothelial carcinoma associated with the use of a chinse herb (Aristolochia fangchi)
36. Cancer and herbs
37. A case of drug induced pneumonitis caused by Saiboku-To
38. Pneumonitis due to Hangeshashin-to
39. Five cases of pneumonitis induced by Sho-Saiko-to
40. Bronchiolitis obliterans following the ingestion of an Asian shrub leaf
41. Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan
42. Drug-induced lung disease: High-resolution CT findings
43. Amiodarone pulmonary toxicity. Chest radiography and CT in asymptomatic patients
44. Amiodarone pulmonary toxicity: Cytopathology, ultrastructure, and immunocytochemistry
45. Nilutamide pneumonitis: A report on eight patients
46. The lung in inflammatory bowel disease
47. Pleuropulmonary changes induced by ergoline drugs
48. The lung in inflammatory bowel disease
49. Idiopathic pneumonia syndrome after high dose chemotherapy for relapsed Hodgkin's disease
50. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer
51. Idiopathic pneumonia syndrome - Changing spectrum of lung injury after marrow transplantation
52. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
53. Interstitial lung disease induced by exogenous agents: Factors governing susceptibility
54. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: An assessment of risk factors
55. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease
56. Fatal pulmonary fibrosis after a low cumulated dose of bleomycin: Role of alpha1-antitrypsin deficiency?
57. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine
58. Minocycline pneumonitis and eosinophilia: A report on 8 patients
59. Angioedema induced by the angiotensin II blocker losartan
60. Carbamazepine hypersensitivity syndrome: Report of 4 cases and review of the literature
61. Makrolid-antibiotika induzierte vaskulitis (Churg-Strauss-syndrom)
62. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature
63. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos
64. Pleural effusion during bromocriptine exposure in two patients with preexisting asbestos pleural plaques: A relationship?
65. Asbestos, ergot drugs and the pleura
66. Cytochrome P450 3A - Ontogeny and drug disposition
67. ACE inhibitors and cough in Thai patients: A preliminary report
68. Halothane hepatitis in a South African population. Frequency and the influence of gender and ethnicity
69. Angioedema and cough in Nigerian patients receiving ACE inhibitors
70. Hydralazine sensitivity: Clinical features, autoantibody changes and HLA-DR phenotype
71. Inhibition and induction of cytochrome P450 and the clinical implications
72. Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids
73. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel
74. Recall pneumonitis: Adriamycin potentiation of radiation pneumonitis in two children
75. Recall lung pneumonitis due to carmustine after radiotherapy
76. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin
77. Low toxicity with continuous infusion of high-dose bleomycin in poor prognostic testicular cancer
78. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis
79. Pulmonary function in patients receiving long-term low-dose methotrexate
80. Bleomycin-induced pulmonary function abnormalities
81. Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma
82. Pulmonary manifestations of severe ovarian hyperstimulation syndrome: A multicenter study
83. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma
84. Migratory pulmonary infiltrates in a patient treated with sotalol
85. Bronchiolitis obliterans-organizing pneumonia: An Italian experience
86. Transient pulmonary infiltrates: A hypersensitivity reaction to Paclitaxel
87. The histopathology of acute nitrofurantoin-associated pneumonitis
88. Combined nitrofurantoin toxicity to liver and lung
89. Idiosyncratic reactions to carbamazepine mimicking viral infection in children
90. Pseudosepsis syndrome, multiple-system organ failure, and chronic salicylate intoxication. Inhibition of regulatory eicosanoids?
91. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne
92. Serious adverse reactions induced by minocycline: Report of 13 patients and review of the literature
93. DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome associated with nevirapine therapy
94. Anticonvulsant hypersensitivity syndrom occurring as sepsis with multiorgan dysfucntion
95. Medication-induced systemic lupus erythematosus
96. Simvastatin-induced lupus erythematosus
97. Fatal lupus-like syndrome and ARDS induced by fluvastatin
98. A case study and national database report of progressive systemic sclerosis and associated conditions
99. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody
100. Propylthiouracil hypersensitivity: Report of two patients with vasculitis and review of the literature
101. Alternating antineutrophil cytoplasmic antibody specificity. Drug-induced vasculitis in a patient with Wegener's granulomatosis
102. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil
103. Antithyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature
104. Anti-thyroid drug-induced ANCA-associated vasculitis: A case report and review of the literature
105. Minocycline-induced arthritis associated with fever, livedo reticularis, and p-ANCA
106. Vasculitis associated with levamisole and circulating autoantibodies
107. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis
108. ANCA-positive vasculitis associated with allopurinol therapy
109. Aspirin-induced asthma and Churg-Strauss-syndrome
110. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment
111. Churg-Strauss syndrome associated with zafirlukast
112. Zafirlukast and Churg-Strauss syndrome
113. Churg-Strauss syndrome associated with zafirlukast
114. Cytotoxic drug-induced pulmonary disease in infants and children
115. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood
116. Granulomatous pneumonitis following intravesical BCG. What therapy is needed?
117. Systemic granulomatous disease after intravesical BCG instillation
118. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy
119. Piroxicam-induced pulmonary infiltrates and eosinophilia
120. Pneumopathie hypoxémiante sous traitement par IEC
121. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone
122. Nodular bleomycin toxicity
123. Desquamative interstitial pneumonia following long-term nitrofurantoin therapy
124. Diphenylhydantoin-induced lymphocytic interstitial pneumonia
125. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: A possible complication of a new antiarrythmic drug
126. Severe pneumonitis as complication of low-dose methotrexate therapy in psoriasis-related polyarthritis. Reply
127. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with i.v. cyclophosphamide therapy
128. Acute interstitial pneumonitis occurring after consolidation chemotherapy with high-dose cytarabine for acute myelogenous leukemia
129. Acute interstitial pneumonitis related to gemcitabine
130. Recurrent respiratory distress associated with carbamazepine overdose
131. Diffuse alveolar damage following a single administration of a cyclophosphamide containing chemotherapy regimen
132. Penicillamine associated pulmonary hemorrhage
133. Diffuse pulmonary hemorrhage associated with anticoagulant therapy
134. Non fatal pulmonary haemorrhage associated with nitrofurantoin
135. Fatal pulmonary hemorrhage during high-dose valproate monotherapy
136. Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction
137. A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?
138. Possible association of drug therapy with pulmonary alveolar proteinosis (PAP) in patients with malignant haematologicaldisorders
139. Atlas of pulmonary surgical pathology
140. Surgical pathology of non-neoplastic lung disease
141. Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: Classification and diagnostic criteria
142. Bleomycin-induced pulmonary fibrosis after chemotherapy of an ovarian granulosa cell tumor
143. Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin
144. Lipoid pneumonia: A silent complication of mineral oil aspiration
145. Amiodarone lung: Pathologic findings in clinically toxic patients
146. CT-pathology correlation of amiodarone lung
147. Nitrofurantoin-associated acute pulmonary toxicity
148. Peripheral opacities in chronic eosinophilic pneumonia: The photographic negative of pulmonary edema
149. Desquamative interstitial pneumonia: Thin-section CT findings in 22 patients
150. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis